Acute myopericarditis after administration of mRNA vaccines against the SARS-CoV-2 virus

被引：0
|
作者：
Martin, Alba Maria Gomez [1 ]
Martinez-Mateo, Virgilio [1 ]
机构：
[1] Hosp Gen Macha Centro Alcazar San Juan, Serv Med Intensiva, Ciudad Real, Spain
来源：
MEDICINA CLINICA | 2022年 / 158卷 / 12期
关键词：
Pruebas complementarias;
D O I：
10.1016/j.medcli.2021.10.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E11 / E12
页数：2
相关论文
共 50 条
  • [21] Impact of SARS-CoV-2 variants on mRNA vaccines
    Venkatesan, Priya
    LANCET MICROBE, 2021, 2 (09): : E428 - E428
  • [22] Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
    Hsu, Lea
    Wisplinghoff, Hilmar
    Kossow, Annelene
    Hurrass, Julia
    Wiesmueller, Gerhard A.
    Grune, Barbara
    Hoffmann, Dennis
    Luesebrink, Jessica
    Demuth, Sabrina
    Schildgen, Oliver
    Schildgen, Verena
    JOURNAL OF INFECTION, 2022, 84 (01) : 94 - 95
  • [23] Direct Comparison of SARS-CoV-2 Infections after Vaccination with mRNA Vaccines
    Klein, Friederike
    PNEUMOLOGIE, 2022, 76 (08):
  • [24] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [25] Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
    Ying, Baoling
    Whitener, Bradley
    VanBlargan, Laura A.
    Hassan, Ahmed O.
    Shrihari, Swathi
    Liang, Chieh-Yu
    Karl, Courtney E.
    Mackin, Samantha
    Chen, Rita E.
    Kafai, Natasha M.
    Wilks, Samuel H.
    Smith, Derek J.
    Carreno, Juan Manuel
    Singh, Gagandeep
    Krammer, Florian
    Carfi, Andrea
    Elbashir, Sayda M.
    Edwards, Darin K.
    Thackray, Larissa B.
    Diamond, Michael S.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (630)
  • [26] Acute Myopericarditis in a Patient With Mild SARS-CoV-2 Respiratory Infection
    Labani, Aissam
    Germain, Philippe
    Douchet, Marie-Pierre
    Beghi, Mustapha
    Von Hunolstein, Jean Jacques
    Zeyons, Floriane
    Roy, Catherine
    El Ghannudi, Soraya
    CJC OPEN, 2020, 2 (05) : 435 - 437
  • [27] Timely development of vaccines against SARS-CoV-2
    Lu, Shan
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 542 - 544
  • [28] Ensuring Uptake of Vaccines against SARS-CoV-2
    Mello, Michelle M.
    Silverman, Ross D.
    Omer, Saad B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1296 - 1299
  • [29] Messenger RNA vaccines against SARS-CoV-2
    Topol, Eric J.
    CELL, 2021, 184 (06) : 1401 - 1401
  • [30] SARS-CoV-2: Unique Challenges of the Virus and Vaccines
    Mahmoodpoor, Ata
    Sanaie, Sarvin
    Samadi, Parisa
    Yousefi, Mehdi
    Nader, Nader D.
    IMMUNOLOGICAL INVESTIGATIONS, 2021, 50 (07) : 802 - 809
12345